Kevin Xie, MBA;PhD

Dr. Xie has served as CFO of Gracell Biotechnologies since July 2020. He has over 18 years of finance and investment experience in leading healthcare investment organizations. Prior to joining Gracell, Dr. Xie served as the President of Fosun Healthcare Holdings and Chief Representative of Fosun, New York. Dr. Xie co-founded and served as Portfolio Manager of Locust Walk Capital. He had previously served as Healthcare Sector Head at Scopia Capital, and as a Managing Director at Great Point Partners. He is currently on the Board of Directors at Humanigen Inc. (Nasdaq:HGEN). Dr. Xie holds a Ph.D. in chemistry from The City University in New York, and an M.B.A in finance from The Wharton School, University of Pennsylvania.